| human | Q5 |
| P496 | ORCID iD | 0000-0001-9950-1232 |
| P69 | educated at | Massachusetts Institute of Technology | Q49108 |
| Washington University in St. Louis | Q777403 | ||
| Memorial Sloan Kettering Cancer Center | Q1808012 | ||
| Columbia University Vagelos College of Physicians and Surgeons | Q2154182 | ||
| P108 | employer | Barbara Ann Karmanos Cancer Institute | Q4858714 |
| P735 | given name | ??? | Q18336566 |
| ??? | Q18336566 | ||
| P106 | occupation | researcher | Q1650915 |
| Q112749085 | PAK4-NAMPT Dual Inhibition Sensitizes Pancreatic Neuroendocrine Tumors to Everolimus |
| Q91646349 | PAK4-NAMPT Dual Inhibition as a Novel Strategy for Therapy Resistant Pancreatic Neuroendocrine Tumors |
| Q91930702 | Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal Adenocarcinoma |
| Q37349434 | Safety and efficacy of the keystone and rhomboid flaps for immediate reconstruction after wide local excision of non-head and neck melanomas |
| Q90381577 | Targeting Nuclear Exporter Protein XPO1/CRM1 in Gastric Cancer |
Search more.